{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:46:22Z","timestamp":1787316382807,"version":"build-2736575974"},"reference-count":30,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,9,13]]},"abstract":"<jats:p>Background: Dysphagia has been reported as an adverse event for patients receiving rivastigmine for Alzheimer\u2019s disease (AD) treatment. Objective: The purpose of this study was to determine the association between dysphagia and the usage of rivastigmine by using the pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS). Methods: The risk of dysphagia in patients who took rivastigmine was compared with those of patients who took other medications. In addition, this study sought to determine if the dysphagia risk was influenced by sex, age, dosage, and medication routes of administration. Results: When compared to patients prescribed donepezil, galantamine, or memantine, individuals prescribed rivastigmine were almost twice as likely to report dysphagia as an adverse event. The dysphagia risk in individuals prescribed rivastigmine is comparable to individuals prescribed penicillamine but significantly higher than clozapine, drugs of which have been previously shown to be associated with elevated dysphagia likelihood. Individuals older than 80 were 122% more likely to report having dysphagia after being prescribed rivastigmine than patients that were 50\u201370 years of age. Oral administration of rivastigmine was associated with approximately 2 times greater likelihood of reporting dysphagia relative to users of the transdermal patch. In addition, dysphagia showed higher association with pneumonia than other commonly reported adverse events. Conclusion: Patients prescribed rivastigmine were at greater risk of reporting dysphagia as an adverse event than patients prescribed many other medicines. This increase in dysphagia occurrence may be attributed to the dual inhibition of both acetylcholinesterase and butyrylcholinesterase.<\/jats:p>","DOI":"10.3233\/jad-220583","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:03:20Z","timestamp":1660043000000},"page":"721-731","source":"Crossref","is-referenced-by-count":11,"title":["Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System"],"prefix":"10.1177","volume":"89","author":[{"given":"Kun","family":"Bu","sequence":"first","affiliation":[{"name":"Department of Mathematics & Statistics, College of Art and Science, University of South Florida, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devashru","family":"Patel","sequence":"additional","affiliation":[{"name":"College of Computing, Georgia Institute of Technology, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA"},{"name":"Department of Biostatistics & Epidemiology, College of Public Health, University of South Florida, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiru","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Mathematics & Statistics, College of Art and Science, University of South Florida, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibret","family":"Umeukeje","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA"},{"name":"Department of Biostatistics & Epidemiology, College of Public Health, University of South Florida, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220583_ref1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1037\/tps0000124","article-title":"Alterations in hippocampal activity and Alzheimer\u2019s disease","volume":"3","author":"Setti","year":"2017","journal-title":"Transl Issues Psychol Sci"},{"key":"10.3233\/JAD-220583_ref2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/brainsci10120961","article-title":"The association between the usage of non-steroidal anti-inflammatory drugs and cognitive status: Analysis of longitudinal and cross-sectional studies from the Global Alzheimer\u2019s Association Interactive Network and transcriptomic data","volume":"10","author":"Morris","year":"2020","journal-title":"Brain Sci"},{"key":"10.3233\/JAD-220583_ref3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-201551","article-title":"Bradycardia due to donepezil in adults: Systematic analysis of FDA adverse event reporting system","volume":"81","author":"Morris","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220583_ref4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/brainsci11070861","article-title":"The association between tau protein level in cerebrospinal fluid and cognitive status: A large-scale analysis of GAAIN database","volume":"11","author":"Eckhoff","year":"2021","journal-title":"Brain Sci"},{"key":"10.3233\/JAD-220583_ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-220583_ref6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.3233\/JAD-220583_ref7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tjog.2011.10.004","article-title":"Management of moderate to severe Alzheimer\u2019s disease: Focus on memantine","volume":"50","author":"Dominguez","year":"2011","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.3233\/JAD-220583_ref8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.32607\/20758251-2013-5-4-77-82","article-title":"Depolarization-induced calcium-independent synaptic vesicle exo- and endocytosis at frog motor nerve terminals","volume":"5","author":"Abdrakhmanov","year":"2013","journal-title":"Acta Naturae"},{"key":"10.3233\/JAD-220583_ref10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1570159X14666151208112754","article-title":"Current treatment options for Alzheimer\u2019s disease and Parkinson\u2019s disease dementia","volume":"14","author":"Szeto","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-220583_ref11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/WAD.0000000000000316","article-title":"Predictors of discontinuance of oral feeding in patients with advanced Alzheimer dementia and aspiration pneumonia in Japan: A single-center, retrospective observational study","volume":"33","author":"Akuzawa","year":"2019","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-220583_ref12","first-page":"206","article-title":"Dysphagia","volume":"115","author":"Chilukuri","year":"2018","journal-title":"Mo Med"},{"key":"10.3233\/JAD-220583_ref13","doi-asserted-by":"crossref","first-page":"101484","DOI":"10.1016\/j.msard.2019.101484","article-title":"The prevalence and types of oral- and pharyngeal-stage dysphagia in patients with demyelinating diseases based on subjective assessment by the study subjects","volume":"37","author":"Milewska","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.3233\/JAD-220583_ref14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7861\/clinmedicine.14-2-196","article-title":"Swallowing and oropharyngeal dysphagia","volume":"14","author":"O\u2019Rourke","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"10.3233\/JAD-220583_ref15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fnins.2019.00263","article-title":"Cholinergic control ofinflammation, metabolic dysfunction, and cognitive impairment inobesity-associated disorders: Mechanisms and novel therapeuticopportunities","volume":"13","author":"Chang","year":"2019","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-220583_ref16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3233\/JAD-210662","article-title":"The association betweenuse of rivastigmine and pneumonia: Systematicanalysis of FDA Adverse event reporting system","volume":"83","author":"Morris","year":"2021","journal-title":"J AlzheimersDis"},{"key":"10.3233\/JAD-220583_ref18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/bmb\/ldaa024","article-title":"Clozapine in the treatment of refractory schizophrenia: A practical guide for healthcare professionals","volume":"135","author":"Flanagan","year":"2020","journal-title":"Br Med Bull"},{"key":"10.3233\/JAD-220583_ref19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02266997","article-title":"Drug-induced dysphagia","volume":"8","author":"Stoschus","year":"1993","journal-title":"Dysphagia"},{"key":"10.3233\/JAD-220583_ref20","first-page":"595","article-title":"Pharmacological considerations in antipsychotic drug selection for prevention of drug-induced dysphagia","volume":"75","author":"Koshiishi","year":"2020","journal-title":"Pharmazie"},{"key":"10.3233\/JAD-220583_ref21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1345\/aph.1D056","article-title":"Drug-induced esophageal injuries and dysphagia","volume":"37","author":"O\u2019Neill","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.3233\/JAD-220583_ref22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1533317518790038","article-title":"Classification of Alzheimer\u2019s disease stages: An approach using PCA-based algorithm","volume":"33","author":"Ahmad","year":"2018","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-220583_ref23","doi-asserted-by":"crossref","unstructured":"Sadowsky CH , Micca JL , Grossberg GT , Velting DM (2014) Rivastigmine from capsules to patch: Therapeutic advances in the management of Alzheimer\u2019s disease and Parkinson\u2019s disease dementia. Prim Care Companion CNS Disord 16, 10.4088\/PCC.14r01654.","DOI":"10.4088\/PCC.14r01654"},{"key":"10.3233\/JAD-220583_ref24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-019-2718-9","article-title":"Brainstem dysfunction in critically ill patients","volume":"24","author":"Benghanem","year":"2020","journal-title":"Crit Care"},{"key":"10.3233\/JAD-220583_ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-160761","article-title":"Cholinergic modification of neurogenesis and gliosis improves the memory of AbetaPPswe\/PSEN1dE9 Alzheimer\u2019s disease model mice fed a high-fat diet","volume":"56","author":"Matsuda","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220583_ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/ciia.2007.2.1.17","article-title":"Rivastigmine in the treatment of Alzheimer\u2019s disease: An update","volume":"2","author":"Onor","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-220583_ref27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-2999(02)02589-X","article-title":"Effects of huperzine A onacetylcholinesterase isoforms in vitro: Comparison with tacrine,donepezil, rivastigmine and physostigmine.","volume":"455","author":"Zhao","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-220583_ref28","first-page":"313","article-title":"Pseudocholinesterase deficiency: A comprehensive review of genetic, acquired, and drug influences","volume":"78","author":"Soliday","year":"2010","journal-title":"AANA J"},{"key":"10.3233\/JAD-220583_ref29","doi-asserted-by":"crossref","unstructured":"Nordberg A , Ballard C , Bullock R , Darreh-Shori T , Somogyi M (2013) A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease. Prim Care Companion CNS Disord 15, PCC.12r01412.","DOI":"10.4088\/PCC.12r01412"},{"key":"10.3233\/JAD-220583_ref30","doi-asserted-by":"crossref","first-page":"17357","DOI":"10.1038\/srep17357","article-title":"A novel algorithm for analyzing drug-drug interactions from MEDLINE literature","volume":"5","author":"Lu","year":"2015","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220583_ref31","doi-asserted-by":"crossref","first-page":"e0173548","DOI":"10.1371\/journal.pone.0173548","article-title":"Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220583_ref32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40264-018-00792-0","article-title":"A comparison study of algorithms to detect drug-adverse event associations: Frequentist, Bayesian, and machine-learning approaches","volume":"42","author":"Pham","year":"2019","journal-title":"Drug Saf"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:51Z","timestamp":1777370811000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":30,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-220583","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]}}}